文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

慢性肾脏病发病机制和治疗中的内皮因子 第 I 部分:一般机制:欧洲高血压学会内皮素和内皮因子工作组与日本高血压学会的联合共识声明。

Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension.

机构信息

Department of Medicine - DIMED, University of Padova, Padova, Italy.

Molecular Internal Medicine, University of Zürich, Zürich, Switzerland.

出版信息

J Hypertens. 2018 Mar;36(3):451-461. doi: 10.1097/HJH.0000000000001599.


DOI:10.1097/HJH.0000000000001599
PMID:29120962
Abstract

: Kidney damage is a common consequence of arterial hypertension, but is also a cause of atherogenesis. Dysfunction and/or harm of the endothelium in glomeruli and tubular interstitium damage the function of these structures and translates into dynamic changes of filtration fraction, with progressive reduction in glomerular filtration rate, expansion of extracellular fluid volume, abnormal ion balance, and hypoxia, ultimately leading to chronic kidney disease. Considering the key role played by endothelial dysfunction in chronic kidney disease, the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension and the Japanese Society of Hypertension have critically reviewed available knowledge on the mechanisms underlying endothelial cell injury. This resulted into two articles: in the first, we herein examine the mechanisms by which endothelial factors induce vascular remodeling and the role of different players, including endothelin-1, the renin-angiotensin-aldosterone system and their interactions, and of oxidative stress; in the second, we discuss the role of endothelial dysfunction in the major disease conditions that affect the kidney.

摘要

肾脏损伤是动脉高血压的常见后果,但也是动脉粥样硬化形成的原因。肾小球和肾小管间质内皮功能障碍和/或损伤会破坏这些结构的功能,并导致滤过分数的动态变化,肾小球滤过率逐渐降低,细胞外液容量扩张,离子平衡异常和缺氧,最终导致慢性肾脏病。考虑到内皮功能障碍在慢性肾脏病中的关键作用,欧洲高血压学会和日本高血压学会的内皮素和内皮因子工作组对内皮细胞损伤的潜在机制进行了批判性回顾。这导致了两篇文章:第一篇中,我们在此检查了内皮因子诱导血管重塑的机制以及不同参与者(包括内皮素 1、肾素-血管紧张素-醛固酮系统及其相互作用以及氧化应激)的作用;第二篇中,我们讨论了内皮功能障碍在影响肾脏的主要疾病状况中的作用。

相似文献

[1]
Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension.

J Hypertens. 2018-3

[2]
Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part II: Role in disease conditions: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and the Japanese Society of Hypertension.

J Hypertens. 2018-3

[3]
Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.

J Hypertens. 2008-12

[4]
Challenges in the evaluation of endothelial cell dysfunction: a statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors.

J Hypertens. 2023-3-1

[5]
The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice.

PLoS One. 2018-10-3

[6]
Elevated Endothelial Hypoxia-Inducible Factor-1α Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease.

Hypertension. 2015-7

[7]
Hypertension and chronic kidney disease.

Indian Heart J. 2010

[8]
Obesity and insulin resistance in resistant hypertension: implications for the kidney.

Adv Chronic Kidney Dis. 2015-5

[9]
The vascular endothelium in hypertension.

Handb Exp Pharmacol. 2006

[10]
[The role and clinical importance of nitric oxide-endothelin system in hypertension].

Orv Hetil. 2006-9-24

引用本文的文献

[1]
Sex-mediated effects of transglutaminase 2 inhibition on endothelial function in human resistance arteries from diabetic and non-diabetic patients.

Clin Sci (Lond). 2025-1-15

[2]
Endothelin System in Hypertension and Chronic Kidney Disease.

Hypertension. 2024-4

[3]
Peptide 17 alleviates early hypertensive renal injury by regulating the Hippo/YAP signalling pathway.

Nephrology (Carlton). 2022-8

[4]
The Difference between Sacubitril Valsartan and Valsartan on Vascular Endothelial Function, APN, MMP-9, and BNP Levels in Patients with Hypertension and Chronic Heart Failure.

J Healthc Eng. 2022

[5]
Endothelial Glycocalyx as a Regulator of Fibrotic Processes.

Int J Mol Sci. 2021-3-15

[6]
Mechanism of herbal medicine on hypertensive nephropathy (Review).

Mol Med Rep. 2021-4

[7]
Evaluation of Allostatic Load as a Mediator of Sleep and Kidney Outcomes in Black Americans.

Kidney Int Rep. 2018-12-18

[8]
Inhibition of Soluble Epoxide Hydrolase for Renal Health.

Front Pharmacol. 2019-1-10

[9]
Endothelium structure and function in kidney health and disease.

Nat Rev Nephrol. 2019-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索